CSIMarket
 


Astrazeneca Plc  (AZN)
Other Ticker:  
 


Astrazeneca Plc's ROA from the fourth quarter of 2023 to the fourth quarter of 2022 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Astrazeneca Plc's ROA in the fourth quarter of 2023?
Astrazeneca Plc achieved a return on average assets (ROA) of 5.9 % in its fourth quarter of 2023 a new company high.

ROA has improved compared to 3.29% in the third quarter of 2023, due to net income growth.

However, within the Healthcare sector 79 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2023 from to 783.

What is ROA?


Return On Assets (Dec 31 2023)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Total Assets Change 4.8 % 4.8 % 4.8 % 4.8 % -8.43 %
Y / Y Net Income Change 81.02 % - - - 2763.48 %
Net Income (TTM) in million 5,961 3,293 3,293 3,293 3,293
Return On Assets (TTM) 5.9 % 3.29 % 3.33 % 3.37 % 3.41 %
AZN's Total Ranking # 783 # # # # 1918
Total Assets (TTM) in million 101,119 101,119 101,119 101,119 96,483
Seq. Total Assets Change 0 % 0 % 0 % 4.8 % 0 %
Seq. Net Income Change - - - - -



Return On Assets Company Ranking
Within: No.
Industry # 21
Sector # 80
Overall # 781

Return On Assets Statistics
High Average Low
5.9 %
3.73 %
0.11 %
(Dec 31 2023)   (Dec 31 2021)





Financial Statements
Astrazeneca Plc's Assets $ 101,119 million AZN's Balance sheet
Astrazeneca Plc's Income $ 5,961 million Quarterly AZN's Income Statement
AZN's Income by Division See AZN's Income by Division



Annual Return On Assets (Dec 31 2023)
FY 2023
(Dec 31 2022)
FY 2022
(Dec 31 2021)
FY 2021
(Dec 31 2020)
FY 2020
(Dec 31 2017)
FY 2017
Y / Y Total Assets Change 4.8 % -8.43 % 57.9 % 5.33 % -
Total Assets in million 101,119 96,483 105,363 66,729 63,354
Y / Y Net Income Change 81.02 % 2763.48 % -96.34 % 9.62 % -
Net Income in million 5,961 3,293 115 3,144 2,868
Return On Assets 5.9 % 3.41 % 0.11 % 4.71 % 4.53 %




Comment on AZN's ROA in the fiscal year ending 2023
In the fiscal year 2023 ROA improved to 5.9 % compared to prior year, due to annual net income growth of 81.02 % to $5,961.00 million, while value of Astrazeneca Plc's overall assets grew just by 4.8 % to $101,119.00 million, compared to $101,119.00 a year before.


More Return On Assets Ratios
AZN's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
AZN's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Roa for AZN's Competitors
Roa for Astrazeneca Plc's Suppliers
Return On Assets for AZN's Customers

You may also want to know
AZN's Roi AZN's Inventory Turnover Ratio AZN's Growth Rates AZN's Dividend Comparisons
AZN's Profitability Ratios AZN's Asset Turnover Ratio AZN's Dividend Growth
AZN's Roe AZN's Valuation Ratios AZN's Financial Strength Ratios AZN's Dividend Payout Ratio



Companies with similar Return On Assets at Dec 31 2023, within Healthcare Sector ROA
West Pharmaceutical Services Inc   15.85 %
Halozyme Therapeutics Inc   15.78 %
Edwards Lifesciences Corporation  15.38 %
Exelixis Inc   15.25 %
Novartis Ag  14.86 %
Alpha Pro Tech Ltd   14.69 %
United Therapeutics Corporation  14.47 %
Resmed Inc   13.14 %
Utah Medical Products Inc  13.07 %
Shockwave Medical Inc   12.78 %
Intuitive Surgical Inc   12.73 %
Regeneron Pharmaceuticals Inc   12.56 %
Orasure Technologies Inc  11.57 %
Ufp Technologies Inc   11.28 %
Royalty Pharma Plc  10.24 %
Protalix Biotherapeutics inc   10.17 %
Tactile Systems Technology Inc   10.15 %
Pro dex Inc   10.02 %
Escalon Medical Corp   9.93 %
Hologic Inc  9.68 %
Incyte Corporation  9.49 %
Cadre Holdings Inc   9.42 %
Baxter International Inc   9.25 %
Organon and Co   9.13 %
Eli Lilly And Company  9.12 %
Lemaitre Vascular Inc   9.11 %
Gilead Sciences Inc   9.03 %
Neurocrine Biosciences Inc   9.02 %
Progyny Inc   8.82 %
Electromed Inc   8.76 %


Date modified: 2024-02-21T14:16:37+00:00


Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com